1 |
Ahmadi S, Khanizad A, Fotouhi S. Increases in Pro-inflammatory Cytokines in the Ventral Striatum Following Frequent Morphine Exposure Impose New Setpoints in the Expression of Biologically Relevant Genes to Addiction and Neuroinflammation in Rats. Jentashapir J Cell Mol Biol 2022;13. [DOI: 10.5812/jjcmb-132286] [Reference Citation Analysis]
|
2 |
Soler-cedeno O, Xi Z. Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge. Cells 2022;11:3262. [DOI: 10.3390/cells11203262] [Reference Citation Analysis]
|
3 |
Wiese BM, Liktor-Busa E, Couture SA, Nikas SP, Ji L, Liu Y, Makriyannis A, Spigelman I, Vanderah TW, Largent-Milnes TM. Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression. Cannabis Cannabinoid Res 2022;7:621-7. [PMID: 34935460 DOI: 10.1089/can.2021.0090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Zhang HY, De Biase L, Chandra R, Shen H, Liu QR, Gardner E, Lobo MK, Xi ZX. Repeated cocaine administration upregulates CB2 receptor expression in striatal medium-spiny neurons that express dopamine D1 receptors in mice. Acta Pharmacol Sin 2022;43:876-88. [PMID: 34316031 DOI: 10.1038/s41401-021-00712-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
5 |
Navarrete F, García-gutiérrez MS, Gasparyan A, Navarro D, López-picón F, Morcuende Á, Femenía T, Manzanares J. Biomarkers of the Endocannabinoid System in Substance Use Disorders. Biomolecules 2022;12:396. [DOI: 10.3390/biom12030396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|